Memory Enriched T Cells Following Stem Cell Transplant in Treating Patients With Recurrent B-Cell Non-Hodgkin Lymphoma

Clinical Trial ID NCT02051257

PubWeight™ 7.44‹?›

🔗 Visit the ClinicalTrials.gov page for NCT02051257

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Trial Watch: Adoptive cell transfer for anticancer immunotherapy. Oncoimmunology 2014 0.96
2 Phase 1 studies of central memory-derived CD19 CAR T-cell therapy following autologous HSCT in patients with B-cell NHL. Blood 2016 0.89
3 Cell-based strategies to manage leukemia relapse: efficacy and feasibility of immunotherapy approaches. Leukemia 2014 0.86
4 Trial Watch: Adoptive cell transfer for oncological indications. Oncoimmunology 2015 0.84
5 Adoptive T-cell therapies for refractory/relapsed leukemia and lymphoma: current strategies and recent advances. Ther Adv Hematol 2015 0.82
6 Targeting CD8+ T-cell tolerance for cancer immunotherapy. Immunotherapy 2014 0.81
7 Challenges and opportunities of allogeneic donor-derived CAR T cells. Curr Opin Hematol 2015 0.79
8 Adoptive immunotherapy for acute leukemia: New insights in chimeric antigen receptors. World J Stem Cells 2015 0.78
9 Management of patients with non-Hodgkin's lymphoma: focus on adoptive T-cell therapy. Immunotargets Ther 2015 0.75
Next 100